Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activation of Type I and Type III Interferons in Chronic Hepatitis C.

Journal of innate immunity - 1 Jan 2015

Mihm Sabine

Abstract excerpt

Infection with hepatitis C virus (HCV) results in chronic and progressive liver disease. Persistency rates add up to 85%. Despite recognition of the virus by the human host in peripheral blood and in the liver, immune response appears to be ineffective in clearing infection. The ability to spontaneously eradicate the virus as well as the outcome of infection upon therapy with human recombinant interferon-α...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genetic Variation
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Source

Open in PubMed Open full text

Identifiers

PMID: 25766746
DOI: 10.1159/000369973
PMCID: PMC6738759

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activation of Type I and Type III Interferons in Chronic Hepatitis C.PMID 25766746Read ↗

Innate immunity and HCV.Semantic proximity Read ↗

The Role of Type III Interferons in Hepatitis C Virus Infection and TherapySemantic proximity Read ↗

Innate Immunity in Hepatitis C Virus Infection.Semantic proximity Read ↗

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting AntiviralsSemantic proximity Read ↗

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCVSemantic proximity Read ↗

Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.Semantic proximity Read ↗

Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.Semantic proximity Read ↗

Future landscape of hepatitis C research - Basic, translational and clinical perspectives.Semantic proximity Read ↗

Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery.Semantic proximity Read ↗

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.Semantic proximity Read ↗

Interferon Therapy of Chronic Hepatitis BSemantic proximity Read ↗

A Synopsis of Hepatitis C Virus Treatments and Future PerspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.